The Effect of Opioids on P2Y12 Receptor Inhibition in Patients With ST-Elevation Myocardial Infarction Who Are Pre-treated With Crushed Ticagrelor

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT03400267

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
  • Isala Registry lists this organization as a collaborator
Registry
  • NCT NCT03400267
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03400267. Randomized; no masking; primary purpose treatment. Start 2018-02-16 (actual); primary completion 2019-10-22 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Opioids on P2Y12 Receptor Inhibition in Patients With ST-Elevation Myocardial Infarction Who Are Pre-treated With Crushed Ticagrelor
Acronym
ON-TIME 3
Condition
STEMI
Condition
STEMI - ST Elevation Myocardial Infarction
Intervention (Drug)
Paracetamol
Intervention (Drug)
Fentanyl
Lead sponsor
A.H. Tavenier (class: other)
Collaborator
Isala (class: other)

Record details

Record id
cardio:ct-nct03400267
Content hash
72b7b8fc42a0979b4c4849df4cdc39e7c5496d958f25b76516763d3e26616f37